MicroRNA therapeutics for cardiac regeneration

Mini-Reviews in Medicinal Chemistry

Volumn 15, Issue 6, 2015, Pages 441-451

  Lei, Zhiyong ^a   Sluijter, Joost P G ^a,b   van Mil, Alain ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Cardiac progenitor cells; Cardiomyocytes; Cardiovascular disease; Heart failure; MicroRNA; Regeneration; Stem cells; Transplantation

Indexed keywords

DICER; MICRORNA; MICRORNA 1; MICRORNA 126; MICRORNA 15B; MICRORNA 195; MICRORNA 204; MICRORNA 210; MICRORNA 24; MICRORNA 499; MICRORNA 590; MICRORNA 92A; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CARDIOVASCULAR DISEASE; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL RENEWAL; CELL TRANSPLANTATION; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; MYOBLAST; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; TISSUE REGENERATION; ANIMAL; BIOLOGICAL THERAPY; CARDIOVASCULAR DISEASES; GENETICS; HEART; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATION;

ANIMALS; CARDIOVASCULAR DISEASES; CELL- AND TISSUE-BASED THERAPY; HEART; HUMANS; MICRORNAS; MYOCYTES, CARDIAC; REGENERATION;

EID: 84929298722     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557515666150324123913     Document Type: Article

References (153)

1. Mackay, J.; Mensah, G.A. The Atlas of Heart Disease and Stroke. WHO: 2004.
2. Roger, V.L.; Go, A.S.; Lloyd-Jones, D.M.; Benjamin, E.J.; Berry, J.D.; Borden, W.B.; Bravata, D.M.; Dai, S.; Ford, E.S.; Fox, C.S.; Fullerton, H.J.; Gillespie, C.; Hailpern, S.M.; Heit, J.A.; Howard, V.J.; Kissela, B.M.; Kittner, S.J.; Lackland, D.T.; Lichtman, J.H.; Lisabeth, L.D.; Makuc, D.M.; Marcus, G.M.; Marelli, A.; Matchar, D.B.; Moy, C.S.; Mozaffarian, D.; Mussolino, M.E.; Nichol, G.; Paynter, N.P.; Soliman, E.Z.; Sorlie, P.D.; Sotoodehnia, N.; Turan, T.N.; Virani, S.S.; Wong, N.D.; Woo, D.; Turner, M.B. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation, 2012, 125, e2-e220.
3. Jugdutt, B.I. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation, 2003, 108, 1395-403.
4. Cleutjens, J.P.; Blankesteijn, W.M.; Daemen, M.J.; Smits, J.F. The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc. Res.,, 1999, 44, 232-41.
5. Whelan, R.S.; Kaplinskiy, V.; Kitsis, R.N. Cell death in the pathogenesis of heart disease: mechanisms and significance. Ann. Rev. Physiol., 2010, 72, 19-44.
6. Frangogiannis, N.G. Regulation of the inflammatory response in cardiac repair. Circ. Res., 2012, 110, 159-73.
7. Sutton, M.G.; Sharpe, N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation, 2000, 101, 2981-8.
8. Jugdutt, B.I. Ischemia/Infarction. Heart Failure Clin., 2012, 8, 43- 51.
9. Rubart, M.; Field, L.J. Cardiac regeneration: repopulating the heart. Ann. Rev. Physiol., 2006, 68, 29-49.
10. Laflamme, M.A.; Murry, C.E. Regenerating the heart. Nat. Biotechnol., 2005, 23, 845-56.
11. Virchow, R. Die Cellularpathologie in ihrer Begründung auf physiologische und pathologische Gewebelehre. Berlin: 1858.
12. van der Laan, A.M.; Piek, J.J.; van Royen, N. Targeting angiogenesis to restore the microcirculation after reperfused MI. Nat. Rev. Cardiol., 2009, 6, 515-23.
13. Pasumarthi, K.B.; Field, L.J. Cardiomyocyte cell cycle regulation. Circ. Res., 2002, 90, 1044-54.
14. Rumyantsev, P.P. Post-injury DNA synthesis, mitosis and ultrastructural reorganization of adult frog cardiac myocytes. An electron microscopic-autoradiographic study. Zeitschrift fur Zellforschung und mikroskopische Anatomie, 1973, 139, 431-50.
15. Oberpriller, J.O.; Oberpriller, J.C. Response of the adult newt ventricle to injury. J. exp. Zool., 1974, 187, 249-53.
16. Flink, I.L. Cell cycle reentry of ventricular and atrial cardiomyocytes and cells within the epicardium following amputation of the ventricular apex in the axolotl, Amblystoma mexicanum: confocal microscopic immunofluorescent image analysis of bromodeoxyuridine-labeled nuclei. Anatomy and Embryology, 2002, 205, 235-44.
17. Poss, K.D.; Wilson, L.G.; Keating, M.T. Heart regeneration in zebrafish. Science, 2002, 298, 2188-90.
18. Jopling, C.; Sleep, E.; Raya, M.; Marti, M.; Raya, A.; Izpisua Belmonte, J.C. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature, 2010, 464, 606-9.
19. Bergmann, O.; Bhardwaj, R.D.; Bernard, S.; Zdunek, S.; Barnabe- Heider, F.; Walsh, S.; Zupicich, J.; Alkass, K.; Buchholz, B.A.; Druid, H.; Jovinge, S.; Frisen, J. Evidence for cardiomyocyte renewal in humans. Science, 2009, 324, 98-102.
20. Loffredo, F.S.; Steinhauser, M.L.; Gannon, J.; Lee, R.T. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell, 2011, 8, 389-98.
21. Hsieh, P.C.; Segers, V.F.; Davis, M.E.; MacGillivray, C.; Gannon, J.; Molkentin, J.D.; Robbins, J.; Lee, R.T. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat. Med., 2007, 13, 970-4.
22. Ferreira-Martins, J.; Ogorek, B.; Cappetta, D.; Matsuda, A.; Signore, S.; D'Amario, D.; Kostyla, J.; Steadman, E.; Ide-Iwata, N.; Sanada, F.; Iaffaldano, G.; Ottolenghi, S.; Hosoda, T.; Leri, A.; Kajstura, J.; Anversa, P.; Rota, M. Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells. Circ. Res., 2012, 110, 701-15.
23. van Berlo, J.H.; Kanisicak, O.; Maillet, M.; Vagnozzi, R.J.; Karch, J.; Lin, S.C.; Middleton, R.C.; Marban, E.; Molkentin, J.D. c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature, 2014, 509, 337-41.
24. Liu, J.; Sluijter, J.P.; Goumans, M.J.; Smits, A.M.; van der Spoel, T.; Nathoe, H.; Doevendans, P.A. Cell therapy for myocardial regeneration. Curr. Mol. Med., 2009, 9, 287-98.
25. Ptaszek, L.M.; Mansour, M.; Ruskin, J.N.; Chien, K.R. Towards regenerative therapy for cardiac disease. Lancet, 2012, 379, 933- 42.
26. Hansson, E.M.; Lindsay, M.E.; Chien, K.R. Regeneration next: toward heart stem cell therapeutics. Cell Stem Cell, 2009, 5, 364- 77.
27. van der Spoel, T.I.; Jansen of Lorkeers, S.J.; Agostoni, P.; van Belle, E.; Gyongyosi, M.; Sluijter, J.P.; Cramer, M.J.; Doevendans, P.A.; Chamuleau, S.A. Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. Cardiovasc. Res., 2011, 91, 649-58.
28. Menasche, P.; Alfieri, O.; Janssens, S.; McKenna, W.; Reichenspurner, H.; Trinquart, L.; Vilquin, J.T.; Marolleau, J.P.; Seymour, B.; Larghero, J.; Lake, S.; Chatellier, G.; Solomon, S.; Desnos, M.; Hagege, A.A. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation, 2008, 117, 1189-200.
29. Gnecchi, M.; He, H.; Liang, O.D.; Melo, L.G.; Morello, F.; Mu, H.; Noiseux, N.; Zhang, L.; Pratt, R.E.; Ingwall, J.S.; Dzau, V.J. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med., 2005, 11, 367-8.
30. Vrijsen, K.R.; Chamuleau, S.A.; Noort, W.A.; Doevendans, P.A.; Sluijter, J.P. Stem cell therapy for end-stage heart failure: indispensable role for the cell? Curr. Opin. Organ Transplan., 2009, 14, 560-5.
31. Mirotsou, M.; Jayawardena, T.M.; Schmeckpeper, J.; Gnecchi, M.; Dzau, V.J. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J. Mol. Cell Cardiol., 2011, 50, 280-9.
32. Balsam, L.B.; Wagers, A.J.; Christensen, J.L.; Kofidis, T.; Weissman, I.L.; Robbins, R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature, 2004, 428, 668-73.
33. Hagege, A.A.; Carrion, C.; Menasche, P.; Vilquin, J.T.; Duboc, D.; Marolleau, J.P.; Desnos, M.; Bruneval, P. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet, 2003, 361, 491-2.
34. Leobon, B.; Garcin, I.; Menasche, P.; Vilquin, J.T.; Audinat, E.; Charpak, S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc. Nat. Acad. Sci. USA, 2003, 100, 7808-11.
35. Murry, C.E.; Soonpaa, M.H.; Reinecke, H.; Nakajima, H.; Nakajima, H.O.; Rubart, M.; Pasumarthi, K.B.; Virag, J.I.; Bartelmez, S.H.; Poppa, V.; Bradford, G.; Dowell, J.D.; Williams, D.A.; Field, L.J. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature, 2004, 428, 664-8.
36. Nygren, J.M.; Jovinge, S.; Breitbach, M.; Sawen, P.; Roll, W.; Hescheler, J.; Taneera, J.; Fleischmann, B.K.; Jacobsen, S.E. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med., 2004, 10, 494-501.
37. Reinecke, H.; Poppa, V.; Murry, C.E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J. Mol. Cell Cardiol., 2002, 34, 241-9.
38. Kehat, I.; Kenyagin-Karsenti, D.; Snir, M.; Segev, H.; Amit, M.; Gepstein, A.; Livne, E.; Binah, O.; Itskovitz-Eldor, J.; Gepstein, L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest., 2001, 108, 407-14.
39. Xu, C.; Police, S.; Rao, N.; Carpenter, M.K. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ. Res., 2002, 91, 501-8.
40. Swijnenburg, R.J.; Tanaka, M.; Vogel, H.; Baker, J.; Kofidis, T.; Gunawan, F.; Lebl, D.R.; Caffarelli, A.D.; de Bruin, J.L.; Fedoseyeva, E.V.; Robbins, R.C. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation, 2005, 112, I166-72.
41. Schuldiner, M.; Yanuka, O.; Itskovitz-Eldor, J.; Melton, D.A.; Benvenisty, N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc. Nat. Acad. Sci. USA, 2000, 97, 11307-12.
42. Nussbaum, J.; Minami, E.; Laflamme, M.A.; Virag, J.A.; Ware, C.B.; Masino, A.; Muskheli, V.; Pabon, L.; Reinecke, H.; Murry, C.E. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2007, 21, 1345-57.
43. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007, 131, 861-72.
44. Yu, J.; Vodyanik, M.A.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J.L.; Tian, S.; Nie, J.; Jonsdottir, G.A.; Ruotti, V.; Stewart, R.; Slukvin, II; Thomson, J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007, 318, 1917-20.
45. Efe, J.A.; Hilcove, S.; Kim, J.; Zhou, H.; Ouyang, K.; Wang, G.; Chen, J.; Ding, S. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat. Cell Biol., 2011, 13, 215-22.
46. Ieda, M.; Fu, J.D.; Delgado-Olguin, P.; Vedantham, V.; Hayashi, Y.; Bruneau, B.G.; Srivastava, D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell, 2010, 142, 375-86.
47. Qian, L.; Huang, Y.; Spencer, C.I.; Foley, A.; Vedantham, V.; Liu, L.; Conway, S.J.; Fu, J.D.; Srivastava, D. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature, 2012, 485, 593-8.
48. Xu, H.; Yi, B.A.; Wu, H.; Bock, C.; Gu, H.; Lui, K.O.; Park, J.H.; Shao, Y.; Riley, A.K.; Domian, I.J.; Hu, E.; Willette, R.; Lepore, J.; Meissner, A.; Wang, Z.; Chien, K.R. Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signature. Cell Res., 2012, 22, 142-54.
49. Song, K.; Nam, Y.J.; Luo, X.; Qi, X.; Tan, W.; Huang, G.N.; Acharya, A.; Smith, C.L.; Tallquist, M.D.; Neilson, E.G.; Hill, J.A.; Bassel-Duby, R.; Olson, E.N. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature, 2012, 485, 599-604.
50. Haase, A.; Olmer, R.; Schwanke, K.; Wunderlich, S.; Merkert, S.; Hess, C.; Zweigerdt, R.; Gruh, I.; Meyer, J.; Wagner, S.; Maier, L.S.; Han, D.W.; Glage, S.; Miller, K.; Fischer, P.; Scholer, H.R.; Martin, U. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell, 2009, 5, 434-41.
51. Chen, J.X.; Krane, M.; Deutsch, M.A.; Wang, L.; Rav-Acha, M.; Gregoire, S.; Engels, M.C.; Rajarajan, K.; Karra, R.; Abel, E.D.; Wu, J.C.; Milan, D.; Wu, S.M. Inefficient reprogramming of fibroblasts into cardiomyocytes using gata4, mef2c, and tbx5. Circ. Res., 2012, 111, 50-5.
52. Fu, X.; Xu, Y. Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability. Genome Med., 2012, 4, 55.
53. Zhao, T.; Zhang, Z.N.; Rong, Z.; Xu, Y. Immunogenicity of induced pluripotent stem cells. Nature, 2011, 474, 212-5.
54. Beltrami, A.P.; Barlucchi, L.; Torella, D.; Baker, M.; Limana, F.; Chimenti, S.; Kasahara, H.; Rota, M.; Musso, E.; Urbanek, K.; Leri, A.; Kajstura, J.; Nadal-Ginard, B.; Anversa, P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 2003, 114, 763-76.
55. Oh, H.; Bradfute, S.B.; Gallardo, T.D.; Nakamura, T.; Gaussin, V.; Mishina, Y.; Pocius, J.; Michael, L.H.; Behringer, R.R.; Garry, D.J.; Entman, M.L.; Schneider, M.D. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Nat. Acad. Sci. USA, 2003, 100, 12313-8.
56. Messina, E.; De Angelis, L.; Frati, G.; Morrone, S.; Chimenti, S.; Fiordaliso, F.; Salio, M.; Battaglia, M.; Latronico, M.V.; Coletta, M.; Vivarelli, E.; Frati, L.; Cossu, G.; Giacomello, A. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res., 2004, 95, 911-21.
57. Laugwitz, K.L.; Moretti, A.; Lam, J.; Gruber, P.; Chen, Y.; Woodard, S.; Lin, L.Z.; Cai, C.L.; Lu, M.M.; Reth, M.; Platoshyn, O.; Yuan, J.X.; Evans, S.; Chien, K.R. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature, 2005, 433, 647-53.
58. Bearzi, C.; Rota, M.; Hosoda, T.; Tillmanns, J.; Nascimbene, A.; De Angelis, A.; Yasuzawa-Amano, S.; Trofimova, I.; Siggins, R.W.; Lecapitaine, N.; Cascapera, S.; Beltrami, A.P.; D'Alessandro, D.A.; Zias, E.; Quaini, F.; Urbanek, K.; Michler, R.E.; Bolli, R.; Kajstura, J.; Leri, A.; Anversa, P. Human cardiac stem cells. Proc. Nat. Acad. Sci. USA, 2007, 104, 14068-73.
59. Goumans, M.J.; de Boer, T.P.; Smits, A.M.; van Laake, L.W.; van Vliet, P.; Metz, C.H.; Korfage, T.H.; Kats, K.P.; Hochstenbach, R.; Pasterkamp, G.; Verhaar, M.C.; van der Heyden, M.A.; de Kleijn, D.; Mummery, C.L.; van Veen, T.A.; Sluijter, J.P.; Doevendans, P.A. TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res., 2007, 1, 138-49.
60. Dey, D.; Han, L.; Bauer, M.; Sanada, F.; Oikonomopoulos, A.; Hosoda, T.; Unno, K.; De Almeida, P.; Leri, A.; Wu, J.C. Dissecting the molecular relationship among various cardiogenic progenitor cells. Circ. Res., 2013, 112, 1253-62.
61. Gaetani, R.; Feyen, D.A.; Doevendans, P.A.; Gremmels, H.; Forte, E.; Fledderus, J.O.; Ramjankhan, F.Z.; Messina, E.; Sussman, M.A.; Giacomello, A.; Sluijter, J.P. Different types of cultured human adult Cardiac Progenitor Cells have a high degree of transcriptome similarity. J. Cell. Mol. Med., 2014, 18, 2147-51.
62. Smits, A.M.; van Oorschot, A.A.; Goumans, M.J. Isolation and differentiation of human cardiomyocyte progenitor cells into cardiomyocytes. Methods Mol. Biol., 2012, 879, 339-49.
63. Smits, A.M.; van Vliet, P.; Metz, C.H.; Korfage, T.; Sluijter, J.P.; Doevendans, P.A.; Goumans, M.J. Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology. Nat. Protocols, 2009, 4, 232-43.
64. den Haan, M.C.; Grauss, R.W.; Smits, A.M.; Winter, E.M.; van Tuyn, J.; Pijnappels, D.A.; Steendijk, P.; Gittenberger-De Groot, A.C.; van der Laarse, A.; Fibbe, W.E.; de Vries, A.A.; Schalij, M.J.; Doevendans, P.A.; Goumans, M.J.; Atsma, D.E. Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts. J. Cell Mol. Med., 2012, 16, 1508-1521.
65. Smits, A.M.; van Laake, L.W.; den Ouden, K.; Schreurs, C.; Szuhai, K.; van Echteld, C.J.; Mummery, C.L.; Doevendans, P.A.; Goumans, M.J. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc. Res., 2009, 83, 527-35.
66. Chimenti, I.; Smith, R.R.; Li, T.S.; Gerstenblith, G.; Messina, E.; Giacomello, A.; Marban, E. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ. Res., 2010, 106, 971-80.
67. Tang, X.L.; Rokosh, G.; Sanganalmath, S.K.; Yuan, F.; Sato, H.; Mu, J.; Dai, S.; Li, C.; Chen, N.; Peng, Y.; Dawn, B.; Hunt, G.; Leri, A.; Kajstura, J.; Tiwari, S.; Shirk, G.; Anversa, P.; Bolli, R. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation, 2010, 121, 293-305.
68. Makkar, R.R.; Smith, R.R.; Cheng, K.; Malliaras, K.; Thomson, L.E.; Berman, D.; Czer, L.S.; Marban, L.; Mendizabal, A.; Johnston, P.V.; Russell, S.D.; Schuleri, K.H.; Lardo, A.C.; Gerstenblith, G.; Marban, E. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet, 2012, 379, 895-904.
69. Siu, C.W.; Tse, H.F. Cardiac regeneration: messages from CADUCEUS. Lancet, 2012, 379, 870-1.
70. Bolli, R.; Chugh, A.R.; D'Amario, D.; Loughran, J.H.; Stoddard, M.F.; Ikram, S.; Beache, G.M.; Wagner, S.G.; Leri, A.; Hosoda, T.; Sanada, F.; Elmore, J.B.; Goichberg, P.; Cappetta, D.; Solankhi, N.K.; Fahsah, I.; Rokosh, D.G.; Slaughter, M.S.; Kajstura, J.; Anversa, P. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet, 2011, 378, 1847-57.
71. Segers, V.F.; Lee, R.T. Stem-cell therapy for cardiac disease. Nature, 2008, 451, 937-42.
72. Lee, R.C.; Feinbaum, R.L.; Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993, 75, 843-54.
73. Fire, A.; Xu, S.; Montgomery, M.K.; Kostas, S.A.; Driver, S.E.; Mello, C.C. Potent and specific genetic interference by doublestranded RNA in Caenorhabditis elegans. Nature, 1998, 391, 806- 11.
74. Lagos-Quintana, M.; Rauhut, R.; Lendeckel, W.; Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science, 2001, 294, 853-8.
75. Lau, N.C.; Lim, L.P.; Weinstein, E.G.; Bartel, D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science, 2001, 294, 858-62.
76. Lee, R.C.; Ambros, V. An extensive class of small RNAs in Caenorhabditis elegans. Science, 2001, 294, 862-4.
77. Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116, 281-97.
78. Lee, Y.; Ahn, C.; Han, J.; Choi, H.; Kim, J.; Yim, J.; Lee, J.; Provost, P.; Radmark, O.; Kim, S.; Kim, V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature, 2003, 425, 415-9.
79. Gregory, R.I.; Yan, K.P.; Amuthan, G.; Chendrimada, T.; Doratotaj, B.; Cooch, N.; Shiekhattar, R. The Microprocessor complex mediates the genesis of microRNAs. Nature, 2004, 432, 235-40.
80. Lund, E.; Guttinger, S.; Calado, A.; Dahlberg, J.E.; Kutay, U. Nuclear export of microRNA precursors. Science, 2004, 303, 95-8.
81. Hutvagner, G.; McLachlan, J.; Pasquinelli, A.E.; Balint, E.; Tuschl, T.; Zamore, P.D. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science, 2001, 293, 834-8.
82. Gregory, R.I.; Chendrimada, T.P.; Cooch, N.; Shiekhattar, R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell, 2005, 123, 631-40.
83. Bartel, D.P. MicroRNAs: target recognition and regulatory functions. Cell, 2009, 136, 215-33.
84. Guo, H.; Ingolia, N.T.; Weissman, J.S.; Bartel, D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature, 2010, 466, 835-40.
85. Huntzinger, E.; Izaurralde, E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet., 2011, 12, 99-110.
86. Griffiths-Jones, S.; Grocock, R.J.; van Dongen, S.; Bateman, A.; Enright, A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic acid res., 2006, 34, D140-4.
87. Lim, L.P.; Lau, N.C.; Garrett-Engele, P.; Grimson, A.; Schelter, J.M.; Castle, J.; Bartel, D.P.; Linsley, P.S.; Johnson, J.M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 2005, 433, 769-73.
88. Lewis, B.P.; Burge, C.B.; Bartel, D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005, 120, 15-20.
89. Yang, W.J.; Yang, D.D.; Na, S.; Sandusky, G.E.; Zhang, Q.; Zhao, G. Dicer is required for embryonic angiogenesis during mouse development. J. biol. Chem., 2005, 280, 9330-5.
90. Albinsson, S.; Suarez, Y.; Skoura, A.; Offermanns, S.; Miano, J.M.; Sessa, W.C. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler. Thromb. Vasc. Biol., 2010, 30, 1118-26.
91. Suarez, Y.; Fernandez-Hernando, C.; Yu, J.; Gerber, S.A.; Harrison, K.D.; Pober, J.S.; Iruela-Arispe, M.L.; Merkenschlager, M.; Sessa, W.C. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc. Nat. Acad. Sci. USA, 2008, 105, 14082-7.
92. Zhao, Y.; Ransom, J.F.; Li, A.; Vedantham, V.; von Drehle, M.; Muth, A.N.; Tsuchihashi, T.; McManus, M.T.; Schwartz, R.J.; Srivastava, D. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell, 2007, 129, 303- 17.
93. Chen, J.F.; Murchison, E.P.; Tang, R.; Callis, T.E.; Tatsuguchi, M.; Deng, Z.; Rojas, M.; Hammond, S.M.; Schneider, M.D.; Selzman, C.H.; Meissner, G.; Patterson, C.; Hannon, G.J.; Wang, D.Z. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc. Nat. Acad. Sci. USA, 2008, 105, 2111-6.
94. da Costa Martins, P.A.; Bourajjaj, M.; Gladka, M.; Kortland, M.; van Oort, R.J.; Pinto, Y.M.; Molkentin, J.D.; De Windt, L.J. Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation, 2008, 118, 1567-76.
95. Rao, P.K.; Toyama, Y.; Chiang, H.R.; Gupta, S.; Bauer, M.; Medvid, R.; Reinhardt, F.; Liao, R.; Krieger, M.; Jaenisch, R.; Lodish, H.F.; Blelloch, R. Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ. Res., 2009, 105, 585-94.
96. Fish, J.E.; Santoro, M.M.; Morton, S.U.; Yu, S.; Yeh, R.F.; Wythe, J.D.; Ivey, K.N.; Bruneau, B.G.; Stainier, D.Y.; Srivastava, D. miR-126 regulates angiogenic signaling and vascular integrity. Devel. Cell, 2008, 15, 272-84.
97. Wang, S.; Aurora, A.B.; Johnson, B.A.; Qi, X.; McAnally, J.; Hill, J.A.; Richardson, J.A.; Bassel-Duby, R.; Olson, E.N. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Devel. Cell, 2008, 15, 261-71.
98. Liu, N.; Bezprozvannaya, S.; Williams, A.H.; Qi, X.; Richardson, J.A.; Bassel-Duby, R.; Olson, E.N. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes & Devel., 2008, 22, 3242-54.
99. Ikeda, S.; Kong, S.W.; Lu, J.; Bisping, E.; Zhang, H.; Allen, P.D.; Golub, T.R.; Pieske, B.; Pu, W.T. Altered microRNA expression in human heart disease. Physiol. Genom., 2007, 31, 367-73.
100. Thum, T.; Galuppo, P.; Wolf, C.; Fiedler, J.; Kneitz, S.; van Laake, L.W.; Doevendans, P.A.; Mummery, C.L.; Borlak, J.; Haverich, A.; Gross, C.; Engelhardt, S.; Ertl, G.; Bauersachs, J. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation, 2007, 116, 258-67.
101. Matkovich, S.J.; Van Booven, D.J.; Youker, K.A.; Torre-Amione, G.; Diwan, A.; Eschenbacher, W.H.; Dorn, L.E.; Watson, M.A.; Margulies, K.B.; Dorn, G.W., 2nd. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation, 2009, 119, 1263-71.
102. Naga Prasad, S.V.; Duan, Z.H.; Gupta, M.K.; Surampudi, V.S.; Volinia, S.; Calin, G.A.; Liu, C.G.; Kotwal, A.; Moravec, C.S.; Starling, R.C.; Perez, D.M.; Sen, S.; Wu, Q.; Plow, E.F.; Croce, C.M.; Karnik, S. Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J. Biol. Chem., 2009, 284, 27487-99.
103. Sucharov, C.; Bristow, M.R.; Port, J.D. miRNA expression in the failing human heart: functional correlates. J. Mol. Cell. Cardiol., 2008, 45, 185-92.
104. van Rooij, E.; Sutherland, L.B.; Qi, X.; Richardson, J.A.; Hill, J.; Olson, E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science, 2007, 316, 575-9.
105. van Rooij, E.; Sutherland, L.B.; Liu, N.; Williams, A.H.; McAnally, J.; Gerard, R.D.; Richardson, J.A.; Olson, E.N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Nat. Acad. Sci. USA, 2006, 103, 18255-60.
106. da Costa Martins, P.A.; Salic, K.; Gladka, M.M.; Armand, A.S.; Leptidis, S.; el Azzouzi, H.; Hansen, A.; Coenen-de Roo, C.J.; Bierhuizen, M.F.; van der Nagel, R.; van Kuik, J.; de Weger, R.; de Bruin, A.; Condorelli, G.; Arbones, M.L.; Eschenhagen, T.; De Windt, L.J. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat. Cell Biol., 2010, 12, 1220-7.
107. Care, A.; Catalucci, D.; Felicetti, F.; Bonci, D.; Addario, A.; Gallo, P.; Bang, M.L.; Segnalini, P.; Gu, Y.; Dalton, N.D.; Elia, L.; Latronico, M.V.; Hoydal, M.; Autore, C.; Russo, M.A.; Dorn, G.W., 2nd; Ellingsen, O.; Ruiz-Lozano, P.; Peterson, K.L.; Croce, C.M.; Peschle, C.; Condorelli, G. MicroRNA-133 controls cardiac hypertrophy. Nat. Med., 2007, 13, 613-8.
108. Callis, T.E.; Pandya, K.; Seok, H.Y.; Tang, R.H.; Tatsuguchi, M.; Huang, Z.P.; Chen, J.F.; Deng, Z.; Gunn, B.; Shumate, J.; Willis, M.S.; Selzman, C.H.; Wang, D.Z. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest., 2009, 119, 2772-86.
109. Shieh, J.T.; Huang, Y.; Gilmore, J.; Srivastava, D. Elevated miR- 499 levels blunt the cardiac stress response. PloS One, 2011, 6, e19481.
110. Lin, Z.; Murtaza, I.; Wang, K.; Jiao, J.; Gao, J.; Li, P.F. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc. Nat. Acad. Sci. USA, 2009, 106, 12103-8.
111. van Rooij, E.; Sutherland, L.B.; Thatcher, J.E.; DiMaio, J.M.; Naseem, R.H.; Marshall, W.S.; Hill, J.A.; Olson, E.N. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Nat. Acad. Sci. USA, 2008, 105, 13027-32.
112. Matkovich, S.J.; Wang, W.; Tu, Y.; Eschenbacher, W.H.; Dorn, L.E.; Condorelli, G.; Diwan, A.; Nerbonne, J.M.; Dorn, G.W., 2nd. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ. Res., 2010, 106, 166-75.
113. Duisters, R.F.; Tijsen, A.J.; Schroen, B.; Leenders, J.J.; Lentink, V.; van der Made, I.; Herias, V.; van Leeuwen, R.E.; Schellings, M.W.; Barenbrug, P.; Maessen, J.G.; Heymans, S.; Pinto, Y.M.; Creemers, E.E. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ. Res., 2009, 104, 170-8, 6p following 178.
114. Wang, J.X.; Jiao, J.Q.; Li, Q.; Long, B.; Wang, K.; Liu, J.P.; Li, Y.R.; Li, P.F. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat. Med., 2011, 17, 71-8.
115. Hullinger, T.G.; Montgomery, R.L.; Seto, A.G.; Dickinson, B.A.; Semus, H.M.; Lynch, J.M.; Dalby, C.M.; Robinson, K.; Stack, C.; Latimer, P.A.; Hare, J.M.; Olson, E.N.; van Rooij, E. Inhibition of miR-15 protects against cardiac ischemic injury. Circ. Res., 2012, 110, 71-81.
116. Qian, L.; Van Laake, L.W.; Huang, Y.; Liu, S.; Wendland, M.F.; Srivastava, D. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J. Exp. Med., 2011, 208, 549-60.
117. Bonauer, A.; Carmona, G.; Iwasaki, M.; Mione, M.; Koyanagi, M.; Fischer, A.; Burchfield, J.; Fox, H.; Doebele, C.; Ohtani, K.; Chavakis, E.; Potente, M.; Tjwa, M.; Urbich, C.; Zeiher, A.M.; Dimmeler, S. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science, 2009, 324, 1710-3.
118. Hu, S.; Huang, M.; Li, Z.; Jia, F.; Ghosh, Z.; Lijkwan, M.A.; Fasanaro, P.; Sun, N.; Wang, X.; Martelli, F.; Robbins, R.C.; Wu, J.C. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation, 2010, 122, S124-31.
119. Fiedler, J.; Jazbutyte, V.; Kirchmaier, B.C.; Gupta, S.K.; Lorenzen, J.; Hartmann, D.; Galuppo, P.; Kneitz, S.; Pena, J.T.; Sohn-Lee, C.; Loyer, X.; Soutschek, J.; Brand, T.; Tuschl, T.; Heineke, J.; Martin, U.; Schulte-Merker, S.; Ertl, G.; Engelhardt, S.; Bauersachs, J.; Thum, T. MicroRNA-24 regulates vascularity after myocardial infarction. Circulation, 2011, 124, 720-30.
120. Elia, L.; Quintavalle, M.; Zhang, J.; Contu, R.; Cossu, L.; Latronico, M.V.; Peterson, K.L.; Indolfi, C.; Catalucci, D.; Chen, J.; Courtneidge, S.A.; Condorelli, G. The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell death differ., 2009, 16, 1590-8.
121. Xin, M.; Small, E.M.; Sutherland, L.B.; Qi, X.; McAnally, J.; Plato, C.F.; Richardson, J.A.; Bassel-Duby, R.; Olson, E.N. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Devel., 2009, 23, 2166-78.
122. Grueter, C.E.; van Rooij, E.; Johnson, B.A.; DeLeon, S.M.; Sutherland, L.B.; Qi, X.; Gautron, L.; Elmquist, J.K.; Bassel-Duby, R.; Olson, E.N. A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell, 2012, 149, 671-83.
123. Kwon, C.; Han, Z.; Olson, E.N.; Srivastava, D. MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. Proc. Nat. Acad. Sci. USA, 2005, 102, 18986-91.
124. Zhao, Y.; Samal, E.; Srivastava, D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature, 2005, 436, 214-20.
125. Ivey, K.N.; Muth, A.; Arnold, J.; King, F.W.; Yeh, R.F.; Fish, J.E.; Hsiao, E.C.; Schwartz, R.J.; Conklin, B.R.; Bernstein, H.S.; Srivastava, D. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell, 2008, 2, 219-29.
126. Cordes, K.R.; Sheehy, N.T.; White, M.P.; Berry, E.C.; Morton, S.U.; Muth, A.N.; Lee, T.H.; Miano, J.M.; Ivey, K.N.; Srivastava, D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature, 2009, 460, 705-10.
127. Yamaguchi, S.; Yamahara, K.; Homma, K.; Suzuki, S.; Fujii, S.; Morizane, R.; Monkawa, T.; Matsuzaki, Y.; Kangawa, K.; Itoh, H. The role of microRNA-145 in human embryonic stem cell differentiation into vascular cells. Atherosclerosis, 2011, 219, 468- 74.
128. Huang, H.; Xie, C.; Sun, X.; Ritchie, R.P.; Zhang, J.; Chen, Y.E. miR-10a contributes to retinoid acid-induced smooth muscle cell differentiation. J. Biol. Chem., 2010, 285, 9383-9.
129. Xie, C.; Huang, H.; Sun, X.; Guo, Y.; Hamblin, M.; Ritchie, R.P.; Garcia-Barrio, M.T.; Zhang, J.; Chen, Y.E. MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4. Stem Cells Dev., 2011, 20, 205-10.
130. Kane, N.M.; Howard, L.; Descamps, B.; Meloni, M.; McClure, J.; Lu, R.; McCahill, A.; Breen, C.; Mackenzie, R.M.; Delles, C.; Mountford, J.C.; Milligan, G.; Emanueli, C.; Baker, A.H. Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Stem Cells, 2012, 30, 643-54.
131. Sluijter, J.P.; van Mil, A.; van Vliet, P.; Metz, C.H.; Liu, J.; Doevendans, P.A.; Goumans, M.J. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler. Thromb. Vasc. Biol., 2010, 30, 859- 68.
132. Xiao, J.; Liang, D.; Zhang, H.; Liu, Y.; Zhang, D.; Liu, Y.; Pan, L.; Chen, X.; Doevendans, P.A.; Sun, Y.; Liang, X.; Sluijter, J.P.; Chen, Y.H. MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells. J. Mol. Cell. Cardiol., 2012, 53, 751-9.
133. Liu, J.; van Mil, A.; Aguor, E.N.; Siddiqi, S.; Vrijsen, K.; Jaksani, S.; Metz, C.; Zhao, J.; Strijkers, G.J.; Doevendans, P.A.; Sluijter, J.P. MiR-155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPCs) via targeting of MMP-16. J. Cell. Mol. med., 2012, 16, 2379-86.
134. Liu, J.; van Mil, A.; Vrijsen, K.; Zhao, J.; Gao, L.; Metz, C.H.; Goumans, M.J.; Doevendans, P.A.; Sluijter, J.P. MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1. J. Cell. Mol. Med., 2011, 15, 1474-82.
135. Kim, H.W.; Haider, H.K.; Jiang, S.; Ashraf, M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J. Biol. Chem., 2009, 284, 33161-8.
136. Kim, H.W.; Jiang, S.; Ashraf, M.; Haider, K.H. Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function. J. Mol. Med., 2012.
137. Hu, S.; Huang, M.; Nguyen, P.K.; Gong, Y.; Li, Z.; Jia, F.; Lan, F.; Liu, J.; Nag, D.; Robbins, R.C.; Wu, J.C. Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation. Circulation, 2011, 124, S27-34.
138. Porrello, E.R.; Johnson, B.A.; Aurora, A.B.; Simpson, E.; Nam, Y.J.; Matkovich, S.J.; Dorn, G.W., 2nd; van Rooij, E.; Olson, E.N. MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ. Res., 2011, 109, 670-9.
139. Eulalio, A.; Mano, M.; Dal Ferro, M.; Zentilin, L.; Sinagra, G.; Zacchigna, S.; Giacca, M. Functional screening identifies miRNAs inducing cardiac regeneration. Nature, 2012, 492, 376-81.
140. Nam, Y.J.; Song, K.; Luo, X.; Daniel, E.; Lambeth, K.; West, K.; Hill, J.A.; DiMaio, J.M.; Baker, L.A.; Bassel-Duby, R.; Olson, E.N. Reprogramming of human fibroblasts toward a cardiac fate. Proc. Nat. Acad. Sci. USA, 2013, 110, 5588-93.
141. Jayawardena, T.M.; Egemnazarov, B.; Finch, E.A.; Zhang, L.; Payne, J.A.; Pandya, K.; Zhang, Z.; Rosenberg, P.; Mirotsou, M.; Dzau, V.J. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ. Res., 2012, 110, 1465-73.
142. Valadi, H.; Ekstrom, K.; Bossios, A.; Sjostrand, M.; Lee, J.J.; Lotvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol., 2007, 9, 654-9.
143. Gallo, A.; Tandon, M.; Alevizos, I.; Illei, G.G. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PloS One, 2012, 7, e30679.
144. Vrijsen, K.R.; Sluijter, J.P.; Schuchardt, M.W.; van Balkom, B.W.; Noort, W.A.; Chamuleau, S.A.; Doevendans, P.A. Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. J. Cell. Mol. Med., 2010, 14, 1064-70.
145. Sluijter, J.P.; Verhage, V.; Deddens, J.C.; van den Akker, F.; Doevendans, P.A. Microvesicles and exosomes for intracardiac communication. Cardiovasc. Res., 2014, 102, 302-11.
146. Katare, R.; Riu, F.; Mitchell, K.; Gubernator, M.; Campagnolo, P.; Cui, Y.; Fortunato, O.; Avolio, E.; Cesselli, D.; Beltrami, A.P.; Angelini, G.; Emanueli, C.; Madeddu, P. Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro- RNA-132. Circ. Res., 2011, 109, 894-906.
147. Krutzfeldt, J.; Kuwajima, S.; Braich, R.; Rajeev, K.G.; Pena, J.; Tuschl, T.; Manoharan, M.; Stoffel, M. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acid Res., 2007, 35, 2885-92.
148. Krutzfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K.G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of microRNAs in vivo with 'antagomirs'. Nature, 2005, 438, 685-9.
149. Elmen, J.; Lindow, M.; Schutz, S.; Lawrence, M.; Petri, A.; Obad, S.; Lindholm, M.; Hedtjarn, M.; Hansen, H.F.; Berger, U.; Gullans, S.; Kearney, P.; Sarnow, P.; Straarup, E.M.; Kauppinen, S. LNAmediated microRNA silencing in non-human primates. Nature, 2008, 452, 896-9.
150. Lanford, R.E.; Hildebrandt-Eriksen, E.S.; Petri, A.; Persson, R.; Lindow, M.; Munk, M.E.; Kauppinen, S.; Orum, H. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science, 2010, 327, 198-201.
151. Ebert, M.S.; Neilson, J.R.; Sharp, P.A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Met., 2007, 4, 721-6.
152. Wang, K.; Long, B.; Zhou, J.; Li, P.F. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy. J. Biol. Chem., 2010, 285, 11903-12.
153. Kwekkeboom, R.F.; Lei, Z.; Doevendans, P.A.; Musters, R.J.; Sluijter, J.P. Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges. Clin. Sci. (Lond), 2014, 127, 351-65.